Biotech investors have been predicting Amgen 's (NASDAQ: AMGN) potential purchase of  Alexion Pharmaceuticals (NASDAQ: ALXN) for over a year, and the rumor has picked up steam following signals that the big biotech is ready to make some deals.  At a rumored offering price of $20...

Is a major biotech buyout in the works? Spanish television network Intereconomia recently reported that Amgen (NASDAQ: AMGN) is in discussions to acquire Alexion Pharmaceuticals (NASDAQ: ALXN) . Intereconomia cited unnamed sources that said a deal could be announced soon, with Amgen pot...

A potential deal for Amgen (NASDAQ: AMGN ) to buy Alexion Pharmaceuticals (NASDAQ: ALXN ) “would be highly accretive,” Mizuho says. More news on: Amgen Inc., Alexion Pharmaceuticals, Inc., Merger & acquisition news, Stocks on the move, Healthcare stocks news, Read mor...